A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance.
about
Occurrence of pfatpase6 Single Nucleotide Polymorphisms Associated with Artemisinin Resistance among Field Isolates of Plasmodium falciparum in North-Eastern TanzaniaAntimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR NetworkThe interplay between drug resistance and fitness in malaria parasitesUsing genetic methods to define the targets of compounds with antimalarial activityStructural polymorphism in the promoter ofpfmrp2confersPlasmodium falciparumtolerance to quinoline drugsA HECT ubiquitin-protein ligase as a novel candidate gene for altered quinine and quinidine responses in Plasmodium falciparumPfCRT and its role in antimalarial drug resistanceProbing the multifactorial basis of Plasmodium falciparum quinine resistance: Evidence for a strain-specific contribution of the sodium-proton exchanger PfNHECharacterization of two putative potassium channels in Plasmodium falciparumTowards genome-wide experimental genetics in the in vivo malaria model parasite Plasmodium bergheiGenome-wide compensatory changes accompany drug- selected mutations in the Plasmodium falciparum crt geneIdentification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparumAntimalarial exposure delays Plasmodium falciparum intra-erythrocytic cycle and drives drug transporter genes expressionCharacterization of the commercially-available fluorescent chloroquine-BODIPY conjugate, LynxTag-CQGREEN, as a marker for chloroquine resistance and uptake in a 96-well plate assayEvolution of Fitness Cost-Neutral Mutant PfCRT Conferring P. falciparum 4-Aminoquinoline Drug Resistance Is Accompanied by Altered Parasite Metabolism and Digestive Vacuole PhysiologyInvestigation of the Plasmodium falciparum food vacuole through inducible expression of the chloroquine resistance transporter (PfCRT)Glutathione transport: a new role for PfCRT in chloroquine resistanceChloroquine transport via the malaria parasite's chloroquine resistance transporterMultiple drugs compete for transport via the Plasmodium falciparum chloroquine resistance transporter at distinct but interdependent sitesChloroquine-resistant isoforms of the Plasmodium falciparum chloroquine resistance transporter acidify lysosomal pH in HEK293 cells more than chloroquine-sensitive isoforms.High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinationsDiverse mutational pathways converge on saturable chloroquine transport via the malaria parasite's chloroquine resistance transporterResistance to antimalarial drugs: molecular, pharmacologic, and clinical considerations.PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX.Transporters involved in resistance to antimalarial drugs.Evidence that mutant PfCRT facilitates the transmission to mosquitoes of chloroquine-treated Plasmodium gametocytes4-aminoquinolines active against chloroquine-resistant Plasmodium falciparum: basis of antiparasite activity and quantitative structure-activity relationship analysesIn vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipineHigh frequency of Plasmodium falciparum chloroquine resistance marker (pfcrt T76 mutation) in Yemen: an urgent need to re-examine malaria drug policy.Polymorphisms of molecular markers of antimalarial drug resistance and relationship with artesunate-mefloquine combination therapy in patients with uncomplicated Plasmodium falciparum malaria in Thailand.Plasmodium falciparum chloroquine resistance transporter is a H+-coupled polyspecific nutrient and drug exporter.Monitoring PfMDR1 transport in Plasmodium falciparum.Genome-wide transcriptome profiling reveals functional networks involving the Plasmodium falciparum drug resistance transporters PfCRT and PfMDR1Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter.Drug-resistant malariaMolecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China.Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005.Assessing the cost-benefit effect of a Plasmodium falciparum drug resistance mutation on parasite growth in vitro.
P2860
Q21284494-E308D96C-5319-4E2D-878C-F0FD1EFF7B38Q26799713-A0BAABC2-F836-432D-B0E2-3B257728600AQ26998596-C20262AB-42D6-438E-8317-73826294AA97Q27014788-FD359C3F-984B-45A9-86CB-C9F9A163D421Q27861940-7391815D-6A08-46F5-BC1E-0E339BB220A2Q27861949-ECBF0C0B-40CE-44B2-A08F-D857F4633818Q27861957-90F42B82-B435-4573-A730-DE34A95484A7Q27861959-F5914252-DDE4-4F9F-B721-9E41F6CB741BQ27974357-1008E105-DA3A-4A73-AF11-D803708D43C9Q28084219-A1540690-00ED-4E19-BF77-47A5C8C52F8FQ28472981-B556C28C-8453-4CD0-B8F4-6564D575DC9AQ28473923-2FFFA7C4-07B5-493E-BE8E-F97EE3D82D99Q28475290-60F94232-C9B8-4438-87FE-E6895E970BE1Q28544110-6C843314-7FEC-4EEF-AD77-1EA5836388C3Q28553454-D6C4A784-ED5E-4DF0-9CD3-FFD4C71CAB17Q28728498-6EB2E0AD-BA07-4883-84B4-F0AF0787205EQ30041670-9DF344FB-94F1-4444-BAB0-47ACBE49630DQ30041673-2861E3A2-F43B-43BB-8838-4D47A68DBE28Q30041687-CAEA201C-A0AE-4802-9485-9EBCEBDEC33EQ30357176-E0AFA279-6B45-43CC-A9D6-D20D773CDCDFQ30402235-96B485E4-73C4-4328-8848-0C3306051FEDQ33674606-109C6A51-86AA-4603-BEFD-DA87C8B8DAA9Q33723453-9D5B9D85-BB26-41E4-9F82-8BFAA25A48A6Q34145273-E9B1D4A3-C5B0-4F9D-8B81-064B137C3398Q34151405-3F2D4966-4E77-429C-B01B-356E2B3D1696Q34763527-458B6F06-486D-4331-9F2B-9809E1D8563EQ34932686-D662090A-8707-46D7-8EE7-C52A5E06E359Q35065754-3E984830-D350-4C7A-AB91-C4065CE27826Q35074416-953E239D-80A5-4990-B876-E6A5DEEAD612Q35186886-B6E12422-DAC5-489E-BA56-A28A054BC83DQ35212623-969EF3F5-D82B-4A04-9304-667B33763E87Q35848309-DEAFDB14-5533-4DCC-81C1-E4E58D92A11EQ35874266-230D8509-6541-44E5-8759-EF69322DD89BQ35879787-005363C9-609C-4ABD-A534-D175F6D712C0Q36248426-95938521-A6E2-4BDE-BC0F-24816C5EC327Q36284126-ABD4B70D-6804-49AA-A934-B6C12FC6A676Q36295369-443F2056-9766-4ADD-9D33-AE2520A74545Q36378251-EF1C83EC-F1A9-4FDE-8142-9DD3D9D5ACE7Q36422626-AD676922-86D9-4C93-B840-CE13C43F310DQ36558529-887CC368-227E-4FF2-B362-A54E978FEE0D
P2860
A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A critical role for PfCRT K76T ...... rsible chloroquine resistance.
@en
type
label
A critical role for PfCRT K76T ...... rsible chloroquine resistance.
@en
prefLabel
A critical role for PfCRT K76T ...... rsible chloroquine resistance.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
A critical role for PfCRT K76T ...... ersible chloroquine resistance
@en
P2093
Amar Bir Singh Sidhu
David J Johnson
Dominik Verdier-Pinard
Donald J Krogstad
George E Alakpa
Patrick G Bray
Rebecca A Muhle
Ruth H Hughes
Viswanathan Lakshmanan
P2860
P304
P356
10.1038/SJ.EMBOJ.7600681
P407
P577
2005-06-09T00:00:00Z